Skip to main content

Table 2 RMST results

From: Effects of physician visit frequency for Parkinson’s disease treatment on mortality, hospitalization, and costs: a retrospective cohort study

  Differences in RMST Ratio of RMST
Difference 95% CI P-value Ratio 95% CI P-value
24 months
Unadjusted 1.98 1.42 2.55 <0.01 1.10 1.07 1.13 <0.01
Adjusted
 Intercept 19.99 18.41 21.56 <0.01 19.93 18.43 21.55 <0.01
 Physician visit frequency for PD treatment 1.57 1.05 2.09 <0.01 1.08 1.05 1.11 <0.01
 Sex 1.97 1.42 2.52 <0.01 1.10 1.07 1.13 <0.01
 Age −1.01 −1.32 −0.71 <0.01 0.95 0.94 0.97 <0.01
 Residential facility −0.29 − 0.65 0.07 0.11 0.99 0.97 1.00 0.11
 Long-term care level −1.17 − 1.43 − 0.91 <0.01 0.95 0.93 0.96 <0.01
 Malignancy −1.04 − 1.66 −0.42 <0.01 0.95 0.92 0.98 <0.01
 Ischemic heart disease 0.23 −0.29 0.75 0.39 1.01 0.99 1.04 0.37
 Cerebrovascular disease 0.40 −0.21 1.00 0.20 1.02 0.99 1.05 0.22
 Dyslipidemia 1.37 0.85 1.90 <0.01 1.07 1.04 1.10 <0.01
 Diabetes mellitus 0.45 −0.07 0.96 0.09 1.02 1.00 1.05 0.08
 Dementia 1.61 1.04 2.17 <0.01 1.08 1.05 1.11 <0.01
60 months
Unadjusted 5.72 3.98 7.46 <0.01 1.14 1.10 1.19 <0.01
Adjusted
 Intercept 45.74 37.25 54.22 <0.01 45.46 36.81 56.14 <0.01
 Physician visit frequency for PD treatment 5.00 2.78 7.22 <0.01 1.12 1.06 1.19 <0.01
 Sex 7.66 4.68 10.64 <0.01 1.20 1.11 1.29 <0.01
 Age −4.51 −5.95 −3.08 <0.01 0.90 0.87 0.93 <0.01
 Residential facility −1.72 −3.44 0.01 0.05 0.96 0.91 1.00 0.06
 Long-term care level −3.75 −5.12 −2.38 <0.01 0.92 0.88 0.95 <0.01
 Malignancy −3.42 −6.85 0.01 0.05 0.93 0.85 1.01 0.07
 Ischemic heart disease 0.70 −2.13 3.53 0.63 1.01 0.95 1.08 0.69
 Cerebrovascular disease −0.25 −3.43 2.92 0.88 0.99 0.92 1.07 0.85
 Dyslipidemia 4.66 1.71 7.61 <0.01 1.11 1.04 1.19 <0.01
 Diabetes mellitus 0.09 −2.75 2.93 0.95 1.00 0.94 1.07 0.99
 Dementia 4.59 1.59 7.58 <0.01 1.12 1.04 1.20  
  1. Abbreviation: CI confidence interval, RMST restricted mean survival time